Cargando…
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models
Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation. We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Ne...
Autores principales: | Takahashi, N, Duprez, L, Grootjans, S, Cauwels, A, Nerinckx, W, DuHadaway, J B, Goossens, V, Roelandt, R, Van Hauwermeiren, F, Libert, C, Declercq, W, Callewaert, N, Prendergast, G C, Degterev, A, Yuan, J, Vandenabeele, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542611/ https://www.ncbi.nlm.nih.gov/pubmed/23190609 http://dx.doi.org/10.1038/cddis.2012.176 |
Ejemplares similares
-
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer
por: DuHadaway, James, et al.
Publicado: (2016) -
Necroptosis, necrostatins and tissue injury
por: Smith, Christopher CT, et al.
Publicado: (2011) -
Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
por: Remijsen, Q, et al.
Publicado: (2014) -
Simultaneous targeting of interleukin-1 and interleukin-18 is required for protection against inflammatory and septic shock
por: Berghe, T Vanden, et al.
Publicado: (2014) -
IDO1 is an Integral Mediator of Inflammatory Neovascularization
por: Mondal, Arpita, et al.
Publicado: (2016)